Search research articles
Contact Us
Filters
Showing results (1-10 of 56) with videos related to
Page
of 6
Sort By:
Journal of Proteome Research
|
December 21, 2020
Overview of Targets and Potential Drugs of SARS-CoV-2 According to the Viral Replication
Yi Zhang, Liang V Tang
Current Pharmaceutical Design
|
September 19, 2022
Incidence and Risk Factors of Venous and Arterial Thromboembolism in Immune Checkpoint Inhibitor Therapy
Tingting Liu, Liang V Tang
The Lancet. Oncology
|
June 2, 2020
Poor clinical outcomes for patients with cancer during the COVID-19 pandemic
Liang V Tang, Yu Hu
Journal of Hematology & Oncology
|
June 5, 2021
Hemophagocytic lymphohistiocytosis after COVID-19 vaccination
Liang V Tang, Yu Hu
The Lancet. Oncology
|
April 21, 2023
Strategies for cancer-care resilience during the new COVID-19 wave in China
Liang V Tang, Yu Hu
Frontiers in Nutrition
|
July 1, 2026
Association between CALLY index and all-cause mortality in patients with rheumatoid arthritis
Tong Zhang, Liang V Tang
Experimental Hematology & Oncology
|
August 27, 2024
Genetic factors, risk prediction and AI application of thrombotic diseases
Rong Wang, Liang V Tang, Yu Hu
Lancet (London, England)
|
March 15, 2025
TRiP(cast) score and thrombosis risk for lower limb immobilisation
Liang V Tang, Xuan Lu, Yu Hu
Kidney Diseases (Basel, Switzerland)
|
June 15, 2022
Venous Thromboembolism in Kidney Diseases and Genetic Predisposition
Tingting Wu, Liang V Tang, Yu Hu
Biomarker Research
|
September 5, 2024
Gene therapy for polygenic or complex diseases
Tingting Wu, Yu Hu, Liang V Tang
Page
of 6
Search research articles
Search
Showing results (1-10 of 56) with videos related to
Sort By:
Page
of 6
Journal of Proteome Research
|
December 21, 2020
Overview of Targets and Potential Drugs of SARS-CoV-2 According to the Viral Replication
Yi Zhang, Liang V Tang
Current Pharmaceutical Design
|
September 19, 2022
Incidence and Risk Factors of Venous and Arterial Thromboembolism in Immune Checkpoint Inhibitor Therapy
Tingting Liu, Liang V Tang
The Lancet. Oncology
|
June 2, 2020
Poor clinical outcomes for patients with cancer during the COVID-19 pandemic
Liang V Tang, Yu Hu
Journal of Hematology & Oncology
|
June 5, 2021
Hemophagocytic lymphohistiocytosis after COVID-19 vaccination
Liang V Tang, Yu Hu
The Lancet. Oncology
|
April 21, 2023
Strategies for cancer-care resilience during the new COVID-19 wave in China
Liang V Tang, Yu Hu
Frontiers in Nutrition
|
July 1, 2026
Association between CALLY index and all-cause mortality in patients with rheumatoid arthritis
Tong Zhang, Liang V Tang
Experimental Hematology & Oncology
|
August 27, 2024
Genetic factors, risk prediction and AI application of thrombotic diseases
Rong Wang, Liang V Tang, Yu Hu
Lancet (London, England)
|
March 15, 2025
TRiP(cast) score and thrombosis risk for lower limb immobilisation
Liang V Tang, Xuan Lu, Yu Hu
Kidney Diseases (Basel, Switzerland)
|
June 15, 2022
Venous Thromboembolism in Kidney Diseases and Genetic Predisposition
Tingting Wu, Liang V Tang, Yu Hu
Biomarker Research
|
September 5, 2024
Gene therapy for polygenic or complex diseases
Tingting Wu, Yu Hu, Liang V Tang
Page
of 6